Aclarion (ACONW) Stock: Why It's Down Today
Updated Oct 20, 2026, 4:00 PM ET · closing price
- Closed at $0.02, -12.54% vs the prior close of $0.03.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)
ACONW slides 12.5% to $0.02. Closed at $0.02, -12.54% vs the prior close of $0.03. Day range $0.02–$0.03, opened at $0.05.
ACONW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — ACONW slides 12.5% to $0.02
- Closed at $0.02, -12.54% vs the prior close of $0.03. Day range $0.02–$0.03, opened at $0.05.
- 52-week range $0.02–$0.03; today's close sits at 0% of that range, 12.5% below the 52-week high.
ACONW bull case vs bear case (from the data)
- Annual revenue grew 65.6% in the latest fiscal year (SEC XBRL).
- Insiders made 25 open-market purchases in the last 12 months.
- Latest fiscal-year net income: loss of $7.23M.
- Share count up 394.9% in a year (dilution).
- High volatility: average daily move of 12.5% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
ACONW latest news & SEC filings
Every SEC filing by or about ACONW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
- Williams Amanda M bought 5,857 shares at $2.73 (≈$15.99K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
- Gould Gregory A bought 10,000 shares at $2.45 (≈$24.50K) on Aug 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
- Bond Ryan bought 21,122 shares at $2.37 (≈$50.06K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
- Wesemann William bought 2,150 shares at $2.34 (≈$5.03K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
- Neal David K bought 7,500 shares at $2.40 (≈$18.00K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
- Ness Brent bought 5,234 shares at $2.31 (≈$12.09K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $25.21K (prior year $19.32K) (+30.5% vs Jun 30, 2025)
- Net income: -$2.75M (prior year -$1.60M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.12 (prior year -$2.75) (loss narrowed vs Jun 30, 2025)
Jul 9, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade ACONW
- Last results release: Feb 21, 2024 (8-K Item 2.02). Previous ones: Aug 25, 2023, May 23, 2023, May 16, 2023. Based on that rhythm, the next report is likely around May 22, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 12.54% (largest 12.5%). That is a volatile stock.
- Liquidity: about 4.85K shares (≈$118) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.02 vs a range of $0.02–$0.03 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Amanda M Williams bought 5,857 shares on Aug 17, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Jun 4, 2026; 10-Q May 13, 2026.
- Share count: 2.88M shares outstanding (Aug 4, 2026), +394.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
ACONW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.05 | 0.03 | 0.02 | 0.02 | 9.70K |
| Oct 15, 2026 | 0.05 | 0.03 | 0.03 | 0.03 | 0 |
About Aclarion
Aclarion (ACONW) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in BROOMFIELD, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1635077.
ACONW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ryan Bond | Director | Aug 17, 2026 |
| Scott Breidbart | Director | Jun 12, 2026 |
| Stephen Deitsch | Director | Jun 12, 2026 |
| David K Neal | Director | Aug 17, 2026 |
| Brent Ness | Chief Executive Officer | Aug 17, 2026 |
| Amanda Mae Sequira | Director | Jun 12, 2026 |
| Jeffrey John Thramann | Executive Chairman | Jun 12, 2026 |
| William Wesemann | Director | Aug 17, 2026 |
| Amanda M Williams | Director | Aug 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gregory A Gould | CFO | Aug 18, 2026 |
| Brent Ness | Chief Executive Officer | Aug 17, 2026 |
| Jeffrey John Thramann | Executive Chairman | Jun 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 17, 2026 | Amanda M Williams | Buy | 5,857 | $2.73 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 14, 2026 | Gregory A Gould | Buy | 10,000 | $2.45 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | David K Neal | Buy | 7,500 | $2.40 |
| Aug 13, 2026 | Ryan Bond | Buy | 21,122 | $2.37 |
| Aug 13, 2026 | Ryan Bond | Buy | 21,122 | $2.37 |
| Aug 13, 2026 | Ryan Bond | Buy | 21,122 | $2.37 |
ACONW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $75.73K | $-7.23M | -13.61 | $-7.16M |
| Dec 31, 2024 | $45.72K | $-6.99M | -7,478.90 | $-5.27M |
| Dec 31, 2023 | $75.40K | $-4.91M | -79,782.00 | $-3.65M |
| Dec 31, 2022 | $60.44K | $-7.07M | -19.61 | $-4.95M |
| Dec 31, 2021 | $60.29K | $-4.95M | -6.58 | $-2.40M |
Latest balance sheet: total assets $18.04M, total liabilities $1.04M, cash $16.29M (as of Jun 30, 2026).
ACONW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Feb 21, 2024 | 8-K Item 2.02 (results) | — |
| Aug 25, 2023 | 8-K Item 2.02 (results) | — |
| May 23, 2023 | 8-K Item 2.02 (results) | — |
| May 16, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ACONW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.